Literature DB >> 26215350

Formation and maintenance of the BBB.

Marie Blanchette1, Richard Daneman2.   

Abstract

The central nervous system (CNS) is vascularized by a dense capillary network that is critical to deliver oxygen and nutrients, and remove carbon dioxide and waste products, from the neural tissue. These blood vessels contain a series of properties, termed the blood-brain barrier (BBB), which distinguishes them from vasculature in other tissues, enabling CNS vessels to stringently regulate the transfer of ions, molecules and cells between the blood and the tissue. This barrier is critical to maintain brain homeostasis which allows for proper neuronal function and also to protect the tissue from injury and disease and many neurological diseases are associated with BBB dysfunction, including traumatic brain injuries, Alzheimer's disease, stroke, epilepsy, and multiple sclerosis. Therefore, a better understanding of the mechanisms controlling the development of the BBB may lead to improved comprehension of the pathophysiology of these diseases, and further aid in the identification of targets to modulate the barrier to treat different neurological diseases. Many of the properties of the BBB are possessed by the endothelial cells that form the walls of the blood vessels but are acquired through a series of complex cellular interactions with the microenvironment throughout its development. We will review what is known about the induction and regulation of BBB properties during development.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Blood–brain barrier; Central nervous system; Embryogenesis; Endothelial cells; Neurovascular unit

Mesh:

Year:  2015        PMID: 26215350     DOI: 10.1016/j.mod.2015.07.007

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  77 in total

Review 1.  Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies.

Authors:  Daniel Dubinski; Elke Hattingen; Christian Senft; Volker Seifert; Kevin G Peters; Yvonne Reiss; Kavi Devraj; Karl H Plate
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

Review 2.  Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration.

Authors:  Dale B Bosco; Dai-Shi Tian; Long-Jun Wu
Journal:  FEBS J       Date:  2020-06-15       Impact factor: 5.542

Review 3.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

4.  Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the Rho/ROCK signaling pathway.

Authors:  Fangbin Chen; Zhiyang Liu; Wei Peng; Zhiqin Gao; Hui Ouyang; Tongjun Yan; Songbai Ding; Zhankui Cai; Bin Zhao; Longjin Mao; Zhiyong Cao
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

5.  A transcriptome-based assessment of the astrocytic dystrophin-associated complex in the developing human brain.

Authors:  Matthew J Simon; Charles Murchison; Jeffrey J Iliff
Journal:  J Neurosci Res       Date:  2017-05-16       Impact factor: 4.164

Review 6.  Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

Authors:  Liron L Israel; Anna Galstyan; Eggehard Holler; Julia Y Ljubimova
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

7.  Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation.

Authors:  Brian Wai Chow; Chenghua Gu
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

8.  Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant.

Authors:  Samantha A Garcia; Aurore Lebrun; Rhonda B Kean; D Craig Hooper
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

9.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

10.  Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway.

Authors:  Yonglin Zhao; Xing Wei; Jinning Song; Ming Zhang; Tingqin Huang; Jie Qin
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.